Magnetar Financial LLC Acquires New Position in Spok Holdings, Inc. (NASDAQ:SPOK)

Magnetar Financial LLC bought a new stake in Spok Holdings, Inc. (NASDAQ:SPOK - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 40,329 shares of the Wireless communications provider's stock, valued at approximately $647,000. Magnetar Financial LLC owned 0.20% of Spok at the end of the most recent quarter.

Several other large investors have also modified their holdings of SPOK. Connor Clark & Lunn Investment Management Ltd. raised its holdings in Spok by 133.9% during the fourth quarter. Connor Clark & Lunn Investment Management Ltd. now owns 105,241 shares of the Wireless communications provider's stock worth $1,689,000 after purchasing an additional 60,256 shares in the last quarter. Sanctuary Advisors LLC lifted its holdings in shares of Spok by 4.9% in the 4th quarter. Sanctuary Advisors LLC now owns 27,269 shares of the Wireless communications provider's stock valued at $439,000 after buying an additional 1,271 shares during the period. Allspring Global Investments Holdings LLC boosted its stake in shares of Spok by 67.9% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 110,997 shares of the Wireless communications provider's stock valued at $1,782,000 after buying an additional 44,896 shares in the last quarter. Inspire Investing LLC acquired a new position in Spok during the fourth quarter worth $801,000. Finally, Hennion & Walsh Asset Management Inc. raised its position in Spok by 33.0% in the fourth quarter. Hennion & Walsh Asset Management Inc. now owns 50,221 shares of the Wireless communications provider's stock worth $806,000 after acquiring an additional 12,471 shares in the last quarter. Hedge funds and other institutional investors own 50.81% of the company's stock.

Spok Price Performance

SPOK traded up $0.07 during trading on Wednesday, reaching $16.25. 89,289 shares of the stock were exchanged, compared to its average volume of 116,244. The company has a market capitalization of $331.81 million, a price-to-earnings ratio of 22.26 and a beta of 0.29. Spok Holdings, Inc. has a 1 year low of $13.24 and a 1 year high of $17.96. The business's 50 day moving average price is $16.33 and its two-hundred day moving average price is $15.94.

Spok (NASDAQ:SPOK - Get Free Report) last issued its quarterly earnings data on Wednesday, February 26th. The Wireless communications provider reported $0.18 EPS for the quarter, missing analysts' consensus estimates of $0.20 by ($0.02). The business had revenue of $33.89 million during the quarter, compared to analyst estimates of $35.50 million. Spok had a net margin of 10.66% and a return on equity of 9.20%. On average, analysts anticipate that Spok Holdings, Inc. will post 0.76 EPS for the current year.

Spok Cuts Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Friday, March 14th will be given a dividend of $0.3125 per share. The ex-dividend date is Friday, March 14th. This represents a $1.25 annualized dividend and a dividend yield of 7.69%. Spok's dividend payout ratio is currently 168.92%.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. B. Riley raised shares of Spok from a "neutral" rating to a "buy" rating and upped their price target for the stock from $15.00 to $20.00 in a research note on Thursday, February 27th. StockNews.com upgraded shares of Spok from a "buy" rating to a "strong-buy" rating in a research report on Friday, March 21st.

Spok Company Profile

Spok Holdings, Inc, through its subsidiary, Spok, Inc, provides healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. The company's products and services enhance workflows for clinicians and support administrative compliance. It delivers clinical information to care teams when and where it matters to enhance patient outcomes; and provides GenA Pager, a one-way alphanumeric pager.